Genomic Health

How $2.8B Genomic Health deal catapults Exact beyond Cologuard
How $2.8B Genomic Health deal catapults Exact beyond Cologuard
BioCentury
EXACT Sciences
M&A
Genomic Health
Cologuard
cancer
diagnostics
Flag link:
Exact Sciences Buying Genomic Health in $2.8B Cancer Diagnostics Deal
Exact Sciences Buying Genomic Health in $2.8B Cancer Diagnostics Deal
Xconomy
EXACT Sciences
M&A
Genomic Health
diagostics
Flag link:
This High-Growth Biotech Industry Is as Competitive as Ever Heading Into 2019
This High-Growth Biotech Industry Is as Competitive as Ever Heading Into 2019
Motley Fool
genetic testing
Myriad Genetics
Genomic Health
Invitae
diagnostics
Flag link:
Genomic Health's Oncotype DX Redefines Breast Cancer Therapy
Genomic Health's Oncotype DX Redefines Breast Cancer Therapy
Yahoo/Zacks.com
Oncotype DX
breast cancer
Genomic Health
diagnostics
Flag link:
Creative Destruction And The Pharmaceutical Industry
Creative Destruction And The Pharmaceutical Industry
Seeking Alpha
Genomic Health
Eli Lilly
Novartis
Pfizer
Teva
Flag link:
Hedge Funds Are Buying These 5 Healthcare Stocks With Heavy Short Covering
Hedge Funds Are Buying These 5 Healthcare Stocks With Heavy Short Covering
Seeking Alpha
Affymax
Genomic Health
Incyte
Infinity Pharmaceuticals
MAP Pharmaceuticals
Flag link:
Genomic Health, OncoMed to pursue companion diagnostics
Genomic Health, OncoMed to pursue companion diagnostics
Genomic Health
OncoMed
diagnostics
Flag link:
Relatively Low Operating Margin Detected in Shares of BioMarin Pharmaceutical in the Biotechnology Industry (BMRN, SUPG, ACOR, CPHD, GHDX)
Relatively Low Operating Margin Detected in Shares of BioMarin Pharmaceutical in the Biotechnology Industry (BMRN, SUPG, ACOR, CPHD, GHDX)
Investor's Business Daily
Biomarin
Supergen
Acorda Therapeutics
Cepheid
Genomic Health
Flag link:
4 Healthcare Stocks With Smart Money And Insider Buying
4 Healthcare Stocks With Smart Money And Insider Buying
Seeking Alpha
Sequenom
Akorn
Genomic Health
Theravance
Flag link:
12 Cancer Stocks Being Snapped Up by Insiders
12 Cancer Stocks Being Snapped Up by Insiders
Seeking Alpha
OPKO Health
Tengion
GTx
Anadys
Complete Genomics
Amag Pharmaceuticals
MannKind
Threshold Pharmaceuticals
Synta
Genomic Health
Ziopharm
Ardea
Flag link:
Five Prostate Cancer Diagnostics to Watch
Five Prostate Cancer Diagnostics to Watch
Fierce Biomarkers
prostate cancer
diagnostics
Myriad Genetics
Genomic Health
Oxford Gene Technology
Quanterix
Metamark Genetics
Flag link:
Will Genomic Health's Next Quarter Be a Bomb?
Will Genomic Health's Next Quarter Be a Bomb?
Motley Fool
Genomic Health
Flag link:
Biotech Milestones to Watch in Q3: Obesity Drugs, Genetic Testing and More
Biotech Milestones to Watch in Q3: Obesity Drugs, Genetic Testing and More
BNET Pharma
Vivus
Qnexa
Myriad
Genomic Health
NicOx
naproxcinod
Savient
Krystexxa
Novartis
Gilenia
Seattle Genetics
Gilead Sciences
Chelsea Therapeutics
Eisai
Flag link: